| Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YER120W | SCS2 | SGDID:S000000922 | Vapa Vap33 |
Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33) |
Rattus norvegicus | 1z9l_a | Q9Z270 | 99.50 | 2.30E-18 | 2.30E-22 | 131.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YER120W | SCS2 | SGDID:S000000922 | MSP1 |
Major sperm protein isoform alpha (Alpha-MSP) |
Ascaris suum | 2bvu_b | P27439 | 99.40 | 2.30E-17 | 2.20E-21 | 125.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| YER120W | SCS2 | SGDID:S000000922 | msp-19 F36H12.7; msp-31 R05F9.13; msp-40 C33F10.9; msp-45 F58A6.8; msp-50 C34F11.4; msp-51 ZK354.5; msp-53 R13H9.4; msp-59 ZK354.11; msp-64 ZK1248.6; msp-65 ZK354.1; msp-81 K07F5.1; msp-113 ZK354.4; msp-142 K05F1.2 |
Major sperm protein 19/31/40/45/50/51/53/59/61/65/81/113/142 (MSP) |
Caenorhabditis elegans | 1grw_a | P53017 | 99.70 | 3.30E-22 | 2.70E-26 | 158.50 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||
| YER120W | SCS2 | SGDID:S000000922 | Vapa Vap33 |
Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33) |
Mus musculus | 2cri_a | Q9WV55 | 99.40 | 6.40E-18 | 6.00E-22 | 133.60 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||||
| YER120W | SCS2 | SGDID:S000000922 | VAPB UNQ484/PRO983 |
Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C) |
Homo sapiens | Spinal Muscular Atrophy With Lower Extremity Predominance,Amyotrophic Lateral Sclerosis 7,Amyotrophic Lateral Sclerosis 18,Amyotrophic Lateral Sclerosis 11,Progressive Bulbar Palsy,Amyotrophic Lateral Sclerosis 1,Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1,Amyotrophic Lateral Sclerosis 8,Bronchopneumonia,Lateral Sclerosis,Spinal Muscular Atrophy,Motor Neuron Disease,Muscular Atrophy,Proximal Spinal Muscular Atrophy,Autosomal Dominant Adult-Onset Proximal Spinal Muscular Atrophy,Amyotrophic Lateral Sclerosis 4, Juvenile,Mesenteric Lymphadenitis,Progressive Muscular Atrophy,Disease Of Mental Health,Hemochromatosis, Type 1,Spinal Muscular Atrophy, Late-Onset, Finkel Type,Spinocerebellar Ataxia 2,Amyotrophic Lateral Sclerosis 21,Amyotrophic Lateral Sclerosis 9,Alzheimer Disease 7,Amyotrophic Lateral Sclerosis 10 With Or Without Frontotemporal Dementia,Amyotrophic Lateral Sclerosis 16, Juvenile,Amyotrophic Lateral Sclerosis Type 5,Amyotrophic Lateral Sclerosis Type 6,Amyotrophic Lateral Sclerosis Type 12,Amyotrophic Lateral Sclerosis Type 14,Amyotrophic Lateral Sclerosis Type 15 |
2mdk_a | O95292 | ENSG00000124164 | VAPB | 99.50 | 1.40E-18 | 1.40E-22 | 132.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |